CA2090486A1 - Proteine zp3 de la membrane pellucide humaine - Google Patents

Proteine zp3 de la membrane pellucide humaine

Info

Publication number
CA2090486A1
CA2090486A1 CA002090486A CA2090486A CA2090486A1 CA 2090486 A1 CA2090486 A1 CA 2090486A1 CA 002090486 A CA002090486 A CA 002090486A CA 2090486 A CA2090486 A CA 2090486A CA 2090486 A1 CA2090486 A1 CA 2090486A1
Authority
CA
Canada
Prior art keywords
polypeptide
human
antibodies
exon
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002090486A
Other languages
English (en)
Inventor
Marcel Van Duin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2090486A1 publication Critical patent/CA2090486A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002090486A 1990-08-27 1991-08-13 Proteine zp3 de la membrane pellucide humaine Abandoned CA2090486A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90202287.0 1990-08-27
EP90202287 1990-08-27

Publications (1)

Publication Number Publication Date
CA2090486A1 true CA2090486A1 (fr) 1992-02-28

Family

ID=8205102

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002090486A Abandoned CA2090486A1 (fr) 1990-08-27 1991-08-13 Proteine zp3 de la membrane pellucide humaine

Country Status (12)

Country Link
JP (1) JPH06500690A (fr)
KR (1) KR930702522A (fr)
CN (1) CN1060499A (fr)
AU (1) AU8328591A (fr)
CA (1) CA2090486A1 (fr)
FI (1) FI930897L (fr)
HU (1) HUT64394A (fr)
IE (1) IE912872A1 (fr)
NZ (1) NZ239518A (fr)
PT (1) PT98780A (fr)
WO (1) WO1992003548A1 (fr)
ZA (1) ZA916432B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641487A (en) * 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
AU9094191A (en) * 1990-11-21 1992-06-25 Washington University Recombinant avirulent salmonella antifertility vaccines
WO1994010304A1 (fr) * 1992-11-02 1994-05-11 Akzo Nobel N.V. Proteine zp3 de la zone pellucide du tamarin
US6001599A (en) * 1992-11-09 1999-12-14 Zonagen, Inc. DNAs encoding mammalian ZPBs
DE69333610D1 (de) * 1992-11-09 2004-10-07 Zonagen Inc Methoden für die immunoempfängnisverhütung
AU3471395A (en) * 1994-08-22 1996-03-14 Akzo Nobel N.V. New immunocontraceptive peptides
DE19622289A1 (de) * 1996-05-23 1997-11-27 Schering Ag Zona Pellucida Proteine zur Kontrazeption
BR9908096A (pt) * 1998-02-19 2000-10-31 Eastern Virginia Med School Proteìna 3 da zona pelúcida humana (hzp3), ativa, recombinante
US7037663B2 (en) * 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
EP1421104A4 (fr) 2001-08-02 2005-08-24 Trinity Biomedical Technology Proteines de zone pellucide humaine et methodes d'utilisation associees pour le diagnostic de la sterilite masculine
CN101906163B (zh) * 2009-06-05 2012-06-27 上海交通大学医学院 一种免疫避孕的合成肽和嵌合肽及其应用
EP3847187A1 (fr) * 2018-09-03 2021-07-14 Laboratoire HRA-Pharma Fragments de zp3 en immunothérapie du cancer de l'ovaire

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996297A (en) * 1987-10-07 1991-02-26 Zonagen, Inc. Recombinantly expressed rabbit zona pellucida polypeptides
CA2058999A1 (fr) * 1989-06-12 1990-12-13 Jurrien Dean Vaccin contraceptif base sur un gene clone de la zone pellucide

Also Published As

Publication number Publication date
HUT64394A (en) 1993-12-28
FI930897A7 (fi) 1993-04-05
NZ239518A (en) 1994-03-25
FI930897A0 (fi) 1993-02-26
PT98780A (pt) 1992-07-31
IE912872A1 (en) 1992-03-11
CN1060499A (zh) 1992-04-22
ZA916432B (en) 1992-06-24
FI930897L (fi) 1993-04-05
WO1992003548A1 (fr) 1992-03-05
JPH06500690A (ja) 1994-01-27
KR930702522A (ko) 1993-09-09
AU8328591A (en) 1992-03-17
HU9300537D0 (en) 1993-05-28

Similar Documents

Publication Publication Date Title
Moroianu et al. Mammalian karyopherin alpha 1 beta and alpha 2 beta heterodimers: alpha 1 or alpha 2 subunit binds nuclear localization signal and beta subunit interacts with peptide repeat-containing nucleoporins.
US6264953B1 (en) Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
AU684765B2 (en) Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
WO1992003548A1 (fr) Proteine zp3 de la zona pellucida humaine
AU636895B2 (en) Contraceptive vaccine based on cloned zona pellucida gene
Leelayuwat et al. Antibody reactivity profiles following immunization with diverse peptides of the PERB11 (MIC) family
JPH10505340A (ja) 新規な免疫避妊用ペプチド
TRZYNA et al. Schistosoma mansoni: genetic non‐response to p40, the major protein antigen of the egg, reveals a novel mechanism enhancing IgM production during infection
WO1994010304A1 (fr) Proteine zp3 de la zone pellucide du tamarin
US6455041B1 (en) Immunogenic epitopes of the human zona pellucida protein (ZP1)
WO1990011520A1 (fr) Anticorps contre une chaine lourde de myosine des muscles lisses
AU781486B2 (en) Method for identifying substances which mimic mammal epitopes
WO1997039020A2 (fr) Sequences antigeniques d'une proteine seminale et methodes immunocontraceptives
JP2006516896A (ja) ｅＰＡＤ、卵母細胞特異的タンパク質
Naz applications in infertility and immunocontraception
Naz Cloning and Sequencing of Sperm Antigens Involved in Oocyte Interaction: Clinical applications in infertility and immunocontraception
MXPA97001304A (en) New immunoanticoncepti peptides

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued